Dipender Gill works in Preventive Cardiology affiliated with Novo Nordisk (Denmark).
Dr. Dipender Gill is the CEO and Founder of Sequoia Genetics in the United States. He is also a clinician scientist affiliated with Imperial College London and specializes in General Internal Medicine and Clinical Pharmacology. He previously worked at Novo Nordisk in Denmark, focusing on human genetic data for drug development.
500 pubs · 16,250 cites · h-index 61
BMBCh
University of Oxford
2011
BA
University of Oxford
2008
PhD in Genetic Epidemiology
Imperial College London
2018
Sequoia Genetics
2023 - Present
Imperial College London
2011 - Present
Novo Nordisk
2020 - 2023
National Health Service
2011 - Present